Goldenwell BiotechGWLL 30 Market Cap is $89.10 Mil as of Jul. 12, 2026. GuruFocus rates GWLL with a GF Score™ of 30/100. The stock has 1 warning sign investors should review. Among 2,044 Consumer Packaged Goods companies, Goldenwell Biotech ranks worse than 52.5% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Goldenwell Biotech's share price for the quarter that ended in Mar. 2026 was $1.0035. Goldenwell Biotech's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 99.00 Mil. Therefore, Goldenwell Biotech's market cap for the quarter that ended in Mar. 2026 was $99.35 Mil.
Goldenwell Biotech's quarterly market cap
increased
from Sep. 2025 ($19.80 Mil) to Dec. 2025 ($287.10 Mil) but then
declined
from Dec. 2025 ($287.10 Mil) to Mar. 2026 ($99.35 Mil).
Goldenwell Biotech's annual market cap
increased
from Dec. 2023 ($5.80 Mil) to Dec. 2024 ($19.80 Mil) and
increased
from Dec. 2024 ($19.80 Mil) to Dec. 2025 ($287.10 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Goldenwell Biotech's Enterprise Value for Today is $89.18 Mil.
Goldenwell Biotech (OTCPK:GWLL) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Goldenwell Biotech Market Cap Related Terms
Goldenwell Biotech Market Cap Historical Data
* Premium members only.
The historical data trend for Goldenwell Biotech's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Packaged Foods subindustry, Goldenwell Biotech's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Goldenwell Biotech Market Cap vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Goldenwell Biotech's Market Cap distribution charts can be found below:
* The bar in red indicates where Goldenwell Biotech's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Goldenwell Biotech's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Goldenwell Biotech (GWLL) has a Market Cap of $89.10 Mil as of Jul. 12, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Goldenwell Biotech and its competitors. According to the industry distribution chart, Goldenwell Biotech ranks #1073 out of 2044 companies in the Consumer Packaged Goods industry, placing it in the top 52.5%.
Is Goldenwell Biotech's Market Cap too high?
Goldenwell Biotech's current Market Cap is $89.10 Mil. The Consumer Packaged Goods industry median Market Cap is 103.23. Goldenwell Biotech's value of $89.10 Mil is 13.7% below this industry median. Based on the distribution chart, Goldenwell Biotech ranks #1073 out of 2044 companies in the Consumer Packaged Goods industry, which is below the industry midpoint. Overall, Goldenwell Biotech has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.
How does Goldenwell Biotech's Market Cap compare to HAIN and LSF?
According to the Consumer Packaged Goods industry distribution chart, Goldenwell Biotech ranks #1073 out of 2044 companies for Market Cap. This places Goldenwell Biotech in the lower half of its industry. The industry median Market Cap is 103.23. Goldenwell Biotech's value of $89.10 Mil is 13.7% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Consumer Packaged Goods company?
The median Market Cap among Consumer Packaged Goods companies is 103.23, based on 2,044 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Goldenwell Biotech's current Market Cap of $89.10 Mil is 13.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Goldenwell Biotech and its competitors. For the Consumer Packaged Goods industry, the median Market Cap is 103.23 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Goldenwell Biotech's current Market Cap is $89.10 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Goldenwell Biotech stock overvalued right now?
Goldenwell Biotech (GWLL) has a current Market Cap of $89.10 Mil. The current Market Cap is $89.10 Mil and 13.7% below the Consumer Packaged Goods industry median of 103.23. Goldenwell Biotech's overall GF Score™ is 30/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Goldenwell Biotech (GWLL), the current Market Cap is $89.10 Mil as of Jul. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Goldenwell Biotech Inc is engaged in the research and development, production, and sales of healthcare and supplement products. Its products comprise JI MAI - Bovine Cardiac Vascular Active Peptide, Double Proline AG - 3D Active Collagen Peptide, Cartilage Peptide - Type II collagen peptide, and Sugar Master.
30GF Score
Get the complete analysis for GWLL
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
GWLL has been successfully added to your 
